Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Chlamydophila abortus S26/3, S26/3

>CAB806 putative cysteinyl-tRNA synthetase
MRQSSDNRQNLYLYNTASRTKELFSPSNDPVKLYTCGPTVYDYAHIGNFR
TYIFEDLLKRILLFFGYSVKHVMNITDVDDKTLAGACKNNISLDTYTAPF
IQAFFKDVATLHILPADAYPRATHYIPQMLVAIRKLLDDGIAYIGQDHSV
YFSIKEFPSYGKLSQLQLQNLQCCSRIASDEYDKENLSDFVLWKAYDKHR
DGHIYWESPFGKGRPGWHLECSIMAMELLGPSIDIHAGGVDNIFPHHENE
IAQSESLSHQPFSRYWLHSEHLLVDGKKMSKSLGNFFTLRNLLDRGFSGA
EIRYMLLQSHYRMQLNFTEEGLMACRQALKRLRDFISRLESPYPESATIS
EGIDQCGQRFLQDFSNAIANDLNIAAALASLFDFIHQTNSRIDQSHFTQA
DSHYVLDILKKINTVLGVIPFSTSLEIPSEVARLVEEREIARKEKNWKQA
DVLRNQIASFGYVVEDTKSGPKVKKY
>CAB011 putative 30s ribosomal protein s4
MARYCGPKNRIARRFGANIFGRSRNPLFKKPHPPGQHGMQRKKKSDYGLQ
LEEKQKLKACYGMILEKQLVKAFKEVVNKQGSVTKMFLERFECRLDNMVY
RMGFAKTIFAAQQLVAHGHVLVNGKKVDRRSFFLRPGMQVSLREKSRKLQ
SVKESLENKDESSFPSYISVDKSNFKGELLISPEQDQIEAQLPLPVDVSV
VCEFLSHRT
>CAB849 putative RNA methyltransferase
MLTVSNCKHLGICGGCSSPHSAYADSLKAKERILHELFAPIFPASDILPI
IPCDPLLRGRNKMEFSFFQTKEGEKSLGFITPTKPKQGIPITECLMIHEH
AMDILEITRTWWDRHPEITAYYPPFNKGSLCTLTVRIGSPEHTLMVILTT
SAREEYAVDKKIIEEWKTLLLDSDLPIVSIVWEERVSAKNVPTYFRSNLL
YGEAFIQQKFVLPKDGNSAVFHVRPRSFFQPQTLQGAKIIEVAKEFMDPQ
RSETLLDLYCGAGTIGIMLSQYVKKVIGVEIVPDAIDSAKENILINKKEH
LMEVHLEDVKTFCKRYQDHPSPDVAIIDPPRCGIQNKVLKYLIRIAPRKI
IYISCNPKIQFVECYSLIAAGYRMKKVQPLDQFPHSPHLENIILLEREGH
L
>CAB210 putative rRNA methylase; 4.2.3
MEFIGKNNPKVKEAVALKHNRSRKGPVFLLEGFREIQKALASGYECERIF
CGTRISEKEQAFLHTIQKLPLEKVYCTEETLSKLSYKEHHDNFIAVMKKR
WWSRKEFLAQKRNPLPFYLIIEQVEKPGNVGAILRIADGVGADGVILCDP
IVDVYNPNVIRSSLGTVFTLPIWSATLDQVQQVILEEKWHAFVTSPRAHT
MYFCENYNQPLVLVFGSEKDGLTASWLRGNFSKISLPMLGQADSLNLSTA
VSAVAYEVVRQRWEA
>CAB512 conserved hypothetical protein
MTTKEQFFFKGATSKNKIHFISLGCSRNLVDSEVMLGILLKAGYEATELL
READYLILNTCGFLKAARDESTDYLQRIINEKKETAKIILTGCMVSKHKE
ELKPWLPYVHYVLGSGDVEHILSAIESKESGEKLSSKSYLEMGEVPRKLS
TPKHYAYLKIAEGCRKRCAFCIIPTIKGGLRSKPLEQVMKEFRLLLKMGV
KEIILIAQDLGDYGKDLSKDRKSCLYSVLREMLKEPGNYWIRMLYLYPDE
VDDTLIDLMEKDQRLLPYVDIPLQHINNRVLKKMLRTTSREQILDLLTKL
RTRIPHIYIRSSLIVGFPGETEEEFQELVNFVGEGWIDNLGIFSYSQEKG
SLAAEMPDQIPQSVKSKRLKILSQTQKKNVEKHNKQFVGKIVEAVIDGYH
PDSEFLLTARFYGQAPEVDPCIIVNEARLVSGFGERYLIEITGYVGYDLV
GRVVNKVPGE
>CAB842 putative alanyl-tRNA synthetase
MLSNTLRSNFLKFYANRHHTIVSSSPVFPHNDPSILFTNAGMNQFKDIFL
NKETVSYSRATTSQKCIRAGGKHNDLDNVGHTSRHLTFFEMLGNFSFGDY
FKEQAIAFAWEVSLSVFNFDPDRIYATVHEKDDEAFALWEQHLPSERIFR
LTDKDNFWSMAETGPCGYCSELLFDRGESFGTATSPLEDSEGERFLEYWN
LVFMEFNRSAEGSLLALPNKHVDTGAGLERLVSIISGTNTVFEADVLRLL
ISKTETLSGEKYHADEPLGAAFRVIADHVRSLSFAIVDGLIPGNTERGYV
LRKILRRSVNYGKRLGFTQPFLAEIVPALVDAMGEAYPELRLSVSQIQEV
MTIEEENYFKSLHRGGNLLQQVLKSSSSSSTISGEDAFKLKDTYGLPLDE
IALLAKDYNFSVDLDTFYQLEKEAKERSRKNVIKSHNATDTVYDALSLGE
NSTFVGYHDLSCDTFIEAIIKNGEQVSYLKEKEKGILILKETPFYAEKGG
QVGDSGEIFCSDGTFIVSHTTSPKAGMVIHHGEVSQGQLHSAQAVTAQVH
CLRRKNISNNHTGCHLLHKALEMTLGDHIRQAGSFVDDTKIRLDFTHPKA
IAPEDLASIELLVNEKIRENHRVETREAAYSDVMNSKEIKQFFGDKYSDV
VRVVSAGFSHELCGGTHADFTGDLGYFRILKEHAVATGIRRIEAVTGKEA
EVLARQDNQDLNEIALILQSPRDQILNKLQNILDEKKEQTKLISDLENKL
IYSLLDKVIDRCQQIEDVSYFIYHLPESESHRLQQYANCLHQKIPVRLVS
LWTTQKNGKYIIFSRISDDLVKQGLKAKDLLQVLLTPCGGRWGGKDIFAQ
GSADSLPQADILNNTLCQWISTQLI
>CAB629 conserved hypothetical protein
METKKILKEAAAYLEYCGVVFSDREAVDILMDVLGITSRAQVLSVRLNAD
TLHVYWTRIQKRAERFPTAYIHGSVRFLQLDLEVDSRVLIPRMETELLAE
KIIQYLTQHPHIQTFYDVCCGSGCLGLSIKKYCPNVQVILSDICPKAVAV
AKINASKNHLQVDVLEGDLFAPFSCPADAFVCNPPYLSFDEIMQTDPEVR
CHEPWKALVGGSSGLEFYERIARDLDTILCPGGVGWLEIGYSQGERVKRI
FANHGVHGSIHQDLSACDRIFFLENHASDTVSS
>CAB447 putative ATP/GTP-binding protein
MGHTECGIVGLPNVGKSGLFNALTGAQVASCNYPFCTIDPNIGIVPVIDN
RLDILAKMSQSQKVIYADMKFVDIAGLVKGAADGAGLGNRFLSHIRETHA
VAHVVRCFDNDDVTHVSGKIDPSDDISVINLELIFSDFSSATNIHSKLEK
QAKGKKDLGMVLPLLDRVIKHLESGQPVRTLHLSSEEQIQLKPYPFLTAK
PMLYVANIGEDSIATMHNDYVAVVQEIAKKENAPVVPICVQLEEEIISLP
VEERQDFLNSLGLKESGLHRLVRAAYHTLGLISYFTTGPQETRAWTIPIG
STAAEAAGQIHTDIQKGFIRAEVVTLEDMITYGSRTGVREAGKLRAEGRD
YIVQDGDIMLFLHN
>CAB559 putative queuine tRNA-ribosyltransferase
MALKFHVLHQSKKSRARVGRIETAHGIIDTPAFVPVATNGALKGVVDHSN
IQLMFCNTYHLLVHPGTEAIAAMGGLHKFIHRNSPIITDSGGFQIFSLAY
GSVAEEIKSCGKKKGSSSILEVTDEGVWFKSYRDGSKLFLSPEVSVQAQK
DLGADIIIPLDELLPFHSDTTYFLSSCARTYVWEKRSLDYHKKDPRHQSM
YGVIHGGIDPKQRKIGCAFVEDHPFDGFAIGGSLGRNLNEMVPIVDITTS
YLSKDRPVHLLGIGDLPSIQATIGFGIDSFDSSYPTKAARHGLILSSQGP
IKIANQAYTNDLSPIDPECTCLTCTSKISRAYLRHLFKVHEPNASIWASI
HNLHYMQEFMKNIREQILHDRI
>CAB728 putative cytidine/deoxycytidylate deaminase family protein
MDIEKDIFFMNQALKEARQAYDEDEVPVGCVIVKDNKIIARGHNTTEKLQ
DPTAHAEILCIGAAAQYLENWRLVDTVLYCTLEPCLMCAGAIQLARIRRI
VWAAPDLRLGAGGSWLNVFKEKHPFHQVECFFGICCADAEQLMKQFFIEK
RKEKNEK
>CAB890 putative poly A polymerase
MTTIALEAAKKILLKLRNAGYQAYFVGGCVRDMLMGKPIEEIDIATSAPP
VIVSTIFPDTLAIGAAFGIIVVKENNRLFEVATFRSDENYTDGRHPERVI
FSSMKEDALRRDFTINGMYYDPFEEKLYDLVEGRRDLEKRVIRAIGHPKL
RFSEDKLRILRAIRFSSSLGFTLDPATERAIIKEAPSLVCSVSPERIWQE
LKKMLKKNPYEALSLLIQLKIMTIIFPELRDIPPSLLRTSSEFAKRLNPL
DFPEICFLLPLFQGVSEEAACVAFTRLRISNKDLKLIQLWYQALPQFQNV
SNNRVFWAHFLASPTAHLFLSLFSATQKDPSQQQHFIARVQELEERLEQF
IVRIKTASPLVSAPDLIARGIAPGRLLGDLLKEAEILSIENECHDKEKIL
TLLKEKGFWK
>CAB823 putative tRNA delta(2)-isopentenylpyrophosphate transferase
MFKRTVILLAGPTGSGKTDVSLRLAPMIDGEIISVDSMQVYRGMDIGTAK
VSWEDRQRIPHYLIDICHVQELFNAVDFYYQAIQACQNILSRNKVPILVG
GTGFYFHTFLSGPPQGPSPDCDFRDKLALYIQEHGLSLLYENLCLKDPEY
ARTITKNDRNKIVRALEIIHLTGKKVSDHKWTKEASECQEYNCRGWFLSP
PKELLRDTIHLRCQRMLEDDLIDEVHRLLKQGIRDNSSASRAIGYREWIE
FIDQGSPAESYEAVKQKFITNTCHYTKKQRTWFKRYPIFRELPTLGLTAE
TIAAKIAEDYFLHG
>CAB804 putative ribonuclease P protein component
MYRSTLPKRARVLKRRQFLYISRAGSRCQGSQVIFHVAPSKYPGCCKLGI
TVSKKFGKANKRNYFKRIVREAFRLKRHSLPSCQIVVMPKNKHRPKFEEL
LQDFTQQIPEALNSKFSKNKSTIGGEYSPKNEQCESELP
>CAB758 putative poly(A) polymerase
MVCDNKTLLRRGLELFRKISKSAPTPIIYSAADHNIKLKNFSPHALSVVK
TLRKAGHKAYIVGGCIRDLLLNTTPKDFDISTSAKPEEIKAVFKNCILVG
KRFRLAHIRFSNQIIEVSTFRSGSADEDCLITKDNLWGTAEEDVLRRDFT
INGLFYDPTEETIIDYTGGVSDLENRYLRTIGDPFVRFKQDPVRMLRLLK
ILARAHFTVDPKTLEALQECRYELIKSSQARVFEELIKMLGSGVSSQFFK
LTAKYQILEILFPYMDKAFRLNKTLEEQTFACLDVLDRHIVNKKHNYDRH
QLMAIFLFPIVNFNVRYKHRQYPSLSLTSVFDYIKNFLGKFFADSFTSCS
KKNFILTALILQMQYRLTPLVPTKKIHFFNRKFLNHVRFSEALSLLEIRS
LVYPKLDKILAAWIKHYQALQFKKELPS
>CAB188 putative elongation factor
MSDQEFDLSKIRNIGIMAHIDAGKTTTTERILYYAGRTHKIGEVHEGGAT
MDWMEQEQERGITITSAATTVFWLDCKINIIDTPGHVDFTIEVERSLRVL
DGAVAVFDAVSGVEPQSETVWRQANKYGVPRIAFVNKMDRMGADYFAAVE
SMKEKLGANAVAVHCPIGSESQFVGMVDLISQKALYFLDETLGAKWEERE
IPEELKEKCAELRYALLEELATVDESNEAFMMKVLEDPDAITEEEIHSVM
RKGVIENKINPVLCGTAFKNKGVQQLLNVIVKWLPSPKDRGTIHGINLKN
NEEVYLEPRRDGPLAALAFKIMTDPYVGRITFIRIYSGTLKKGSAILNST
KDKKERISRLLEMHANERTDRDEFTVGDIGACVGLKYSVTGDTLCEENQE
IVLERIEIPEPVIDMAIEPKSKGDREKLAQALSALSEEDPTFRVTSNEEI
GQTIISGMGELHLDILRDRMIREFKVEANVGKPQVSYKETITTSSNSETK
YVKQSGGRGQYAHVCLEIEPNEPGKGNEIVSKIVGGVIPKEYIPAVMKGV
EEGLNTGVLAGYGLVDVKVNIVFGSYHEVDSSEMAFKICGSMAVKEACRK
AAPVILEPIMKIAVITPEDHLGDVIGDLNRRRGKILGQESSRGMAQVNAE
VPLSEMFGYTTSLRSLTSGRATSTMEPAFFAKVPQKIQEEIVKK
>CAB186 putative 30S ribosomal protein s12
MPTINQLIRKKRQSSASRKKSPALQKCPQRRGVCLQVKTKTPKKPNSALR
KVAWVRLSNGQEVIAYIGGEGHNLQEHSIVLVQGGRVKDLPGVRYHIVRG
ALDCAAVKNRKQSRSRYGAKRPK
>CAB260 conserved hypothetical protein
MTVIEVKGTFKLVCLGCRVNQYEIQSYRDQLNFLGYREITDPEIPCDLCI
VNTCAVTGSAESSGRHAVRQVCRQNPDALLVVTGCLGEADKEFFYSLDRQ
CLLVSNKDKHQLMEKIFPSIQDLPEFRIRSFSGKSRAFIKVQDGCNSFCS
YCIIPYLRGRSRSRPVQEILEEISGLVSQGYREVVIAGINVGDYQDQGKS
LAYLISQVDEIPGIERIRISSIDPEDVQDDLRDVLLSGKHTCHSSHLVLQ
SGSNAILKRMNRKYSRGDFLDCVEALRSADPQYTFTTDVIVGFPGETDQD
FEETLRIVEDVGFIKVHIFPFSPRERTKAYTFSSQLPVSVINERKKHLAH
VAREVAYREQRRRIGDTLSVLVERVDEGIAYGHSSYFDMVGFPADPDVSV
NTLIDVRIESVEEDILKGKRV
>CAB959 putative dihydrouridine synthase
MAPSIHIGNILLKSPVVYAPLAGFSDYPYRKMSSFYGPPALMFCEMVKVE
GVHYSPARTLKLLEYSESMRPIGGQLCGSKPEMVGEAAKVLEGLGFDLID
LNCGCPTDRITKDGSGSGLLKSPELIGKVLEKIVEAVSVPVTVKIRSGWD
GSNINVEETVRIIRDAGASAVFVHGRTRAQGYVDPSNLEYIARAKAAAGK
DFPVFGNGDVFSPEAAKLMLDSTQCDGVLVARGTMGAPWIVRQIESYLTS
GTYQKVLFSQRKQAFIQHLQWVEEYYQSEAKFLSETRKLCGHYLISASKV
RFLRSALSKATSVQEVYQLIEDYEEADDEPGETSDLNKC
>CAB669 putative translation initiation factor IF-1
MAKKEDTIVLEGRVKELLPGMHFKILLENGMPVTAHLCGKMRMSNIRLLV
GDRVTVEMSAYDLTKARVVYRHR
>CAB152 conserved hypothetical protein
MHTPQRRATQRKKAPKHEVANLEITGKSFHVSQPLRQLIIEKSSQLPPLD
AIHIVLTSHKEKQGTEVHLTAMGRKETFQVKTQHNNSYSAVIAAFKKIRT
LANKHQKIRQDKKKHDKGLSKKEEQILELEEDIHLYDDLLPLETMDAWDS
LKYYGYIPGSAKKVLSRKKIHLPILSEDEAIKKFEASHNKVLVFLNEKEH
KIQLIHKQNDDNYVLIEPIIAPGFHIF
>CAB720 putative methionine aminopeptidase
MKRNDPCWCGSKRKWKYCHPLAPKLSWEQQKQYYASQYDIILKTPKQIEK
IRHACQITAHILDALCQASKEGVTTEDLDQLSRQLHKEYDAIPAPLNYGS
PPFPKTICTSLNEVICHGIPNNTPLKNGDIMNIDVSCIVDGYYGDCSNMV
MIGEVSEIKKRVCQASLDCLNAAIARLKPYVPLYEIGEAIEACADSYGFS
VVDQFVGHGVGIKFHENPYVPHYRNRSAIPLAPGMIFTIEPMINVGKKEG
VIDPNNHWEARTCDNQPSAQWEHTLLITETGYEILTLLEK
>CAB807 putative lysyl-tRNA synthetase
MSTEAEYLKQEDFLHRSNKLREIVDLGMNPYPYEFPGTTSVEDIKKEYIS
QPLGNSEDATNKETPKVKISGRMVLFRSMGKNAFAQILDNDQKIQVMFNR
DFSSVAGLPVDAEISPIKFIEKKLDLGDILGIEGYLFFTHSGELTILVET
VSLLCKSLISLPDKHAGLSDKETRYRKRWLDLIASDEVRQTFLKRSRIIK
LIRHYMDAQGFIEVETPILQNVYGGAEATPFITMLNALHSEVFLRISPEI
SLKKILVGGTPRIYEIGKVFRNEGIDRTHNPEFTIIEAYATNIDYHSVMT
YVENLVEHLVCELNDGSTVLTYTHLKQGPVSIDFKAPWIRMTMKDSIKTY
GGVDVDLHGDHELRKILKECSSLPEESYMTAPRGSLIAALFDELVCDKLI
APHHITDHPVETTPLCKSLRSGDADFVERFESFCLGKELCNAYSELNDPL
RQRVLLEQQQAKKALDPDSEYHPIDEEFLEALCQGLPPTGGFGIGIDRLV
MILTNAASIRDVLYFPAMRRLESEKD
>CAB081 putative rRNA methylase
MKVVLYHPDIPQNTGNIGRTCIALGAELILVRPLGFSLLDKFVKRAGMDY
WDKVNLSVVDSLDEVLFGVDEDKIFCLSTKGAQYYGDVALPMDGVYVFGS
ESKGLPEEVLKKYYNHTYYLPMQPGIRSLNLATTVGVVLFEAVRQNNQST
CIRTGN
>CAB046 putative elongation factor
MSNFSMETLKLLRQQTGVGLTKCKEALAECNGNLEEAVVYLRKLGLASAS
KKEHRETKEGVIAAKSDSRGTAVVEVNVETDFVANNAVFRTFVDGLVEDV
LNHKVDNVDALLQLPSSQDASLTVDELRAVTMQTVGENIRINRIKYLPKT
TNESVGIYSHGNGKTVSVTVLSGISDEESLAKDISMHIVAAQPLFLNKES
VPEDALAREKEVISSQIQGKPQAVIDKIISGKLGTFFQDVCLLEQAFIKN
PDITIQGLINEASKTRGNSVEVKEFILWKIGA
>CAB538 putative elongation factor
MVLSSQLSVGMFISTKDGLYKVVAVSKVTGNKGESFIKASLKSADSEVII
ERNFKIGQEIKEAQFESRNLEYLYIEDDHFLFLDLGNYEKIHIPKEIMKD
NFLFLKAGVTVSALVYDNVVFSIELPHFLELMVSKTDFPGDSLLIAGGTK
KALLETGIEITVPPFIEIGDIIKIDTRTCEYIQRV
>CAB957 conserved membrane protein
MEKFEFLIPPRTLENDLLDLNKQGILAGPEELKPPFLHRAQDILDHAPDY
PTAFPPRLQEIFDIHPTHLEVIYSNEGMDVWEAGCTWITNNHVTIQLRKH
LRKAARWLYMYSKEEILSHEAVHAARMKFYEPMFEEVLAYQTSPKIWRRF
LGPLFRSPGESYCLFFFVLSGLGLALWSPLAGLACILATPVYFGTRLLIV
QSYFRRAMKKIRKMLGIPPLWVMLRLTDAEIRMFATQPIPVLEKYAREQK
LESVRWQQIYVAYFT
>CAB044 putative ribosome recycling factor
MSILADTEKKMAAALEFFTKEVRSFRTGKANPALVETVTVDVYGTTMRLS
DLASISVADTRQLVISPYDANNVSAISKGIIAANLNLQPDVEGSIVRIKI
PEPTAEYRNEVIKQLRRKSEEAKVAIRNIRRESNDKLKKDSDLTEDAVKG
MEKKIQELTDKFCKQIDKMSKQKEVDLSSI
>CAB498 hypothetical protein
MVNSGVFMSDTDPDVFLQQAADYLDQGKIVAFPTDTVYGLGVALNYPNAE
EKIYALKHRDRGKSLVVYVNTIEDMEKFSGCTLSTRALKLSQKFLPGPLT
LLVDHKNPRFHQEKLGFRILSIPIVNKLIDLAGPLLGTSANISNFPPAIT
SNEVTEDFSQEDICVIPGCCSYGLESTVVSADPLKVYREGMVPRQVIEDV
VGEKVETCLHTRHVFSQHIQVYTVKDEDALNSFLEKNSRFQGVICNNPKP
RDFYPTLRQALRSVEPVAVFIYDPETSAYPELIPYLIPYSYTSPR
>CAB780 putative ribonuclease
MENDILLNIESKEIRYAHLKNGQLFDLIIERKKIRQLKGNIYRGRVTNIL
RNIQSAFINIDERENGFIHISDVLENSKKFEQMFDMDFDVLHQENNEKPE
APIEELLKLDSPVLVQVVKEPIGTKGARLTSNISIPGRYLVLLPNSPHRG
VSRKIEDPHMRDQLKQLIRSFEMPQDMGLICRTASVLASTDALINEAHDL
LATWKGILEKFHSTDQPCLLYEETDILKKAVITCIDKNYKRLLIDDYSTY
QKCKRMLKKYSPNSSVKIEYYRDSIPMFERFNIEKEIDKATKRKIWLSSG
GYLFFDKTEAMHTIDVNSGRSTQLESGVEETLVQINLEAAEEIARQLRLR
NVGGLVIIDFIDMKSRKNQRRVLERLKEHMKYDAARCTILSMSEFGLVEM
TRQRNRESLMQTLFTTCPYCSGNAIIKTPESVVIEIERDLKKVINHKEHT
HLCLVVHPEIASFMKQEQDDDELIRLAKHLKAKLQINTSDSLHLNHYQFF
SLVTGESIEL
>CAB169 ArgS, putative arginyl-tRNA synthetase
MTLLSYLSSLCREAILSAFPQIETISPDITQSTKELFGHYQCNDAMKLAR
TLKMPPRAIAESIVKQISKNNFSSIEIAGAGFINFTFSKEFLNLSLQSYS
RDLSSGFRVQDPKKVVIDFSSPNIAKDMHVGHLRSTIIGDCLARIFTFVG
HDVLRLNHIGDWGTAFGMLITYLQEESSEDIESLEDLTILYKKAHVRFAE
DAEFKKRSQTNVVALQSGDPKARKLWERICEISERAFQKIYNILDIQIEK
RGESFYNPFLPEIIEDLEKKNLITVSDEAKCVFHEGFSIPLMVQKRDGGY
NYATTDLAAMRYRVEQDHADRIIIVTDMGQSLHFQLLEATALAAGYLPNK
DVFSHVGFGLVLDSEGKKFKTRSGENIKLQELLDTAIDQAVATLKKHRPE
MSDAEITERAPVLGMNAIKYADLSSHRVSDYVFSFEKMLRFEGNTAMFIL
YGYVRIQGIKRRLGIEKLSLESAANIQEPSEEALALALLRFPEAIDITLK
ELCPHFLTDYLYMLTNKFHAFFRDCHIEGSPHQKERLYLCALVEKTLATG
MHLLGLQTLDRL
>CAB079 aspS, putative aspartyl-tRNA synthetase
MKYRTHRCNELSLSNVGERVRLSGWVHRYRNHGGVVFIDLRDRFGITQIV
CREDEKPELHQLVDSVRSEWVLSIEGTVCRRLEGMENANLATGEIEVDIE
KVDILSKAKNLPFSISDDHIHVNEELRLEYRYLDMRRGQILDRLVHRHKV
MMACRQYMDKQGFTEVVTPILGKSTPEGARDYLVPSRIYPGSFYALPQSP
QLFKQILMVGGLDRYFQIATCFRDEDLRADRQPEFAQIDIEMSFGTPNDL
FPIIEQLVVEMFAVQGIKIDLPLPRMTYQEAKDLYGTDKPDLRFGLQLHD
CREHAKEFSFSIFLDQLAQGGTIKGFCVPGGADMSRKQLDVYTEFVKRYG
AMGLVWIKKQESGIASNVAKFASEAVFQAMFADFGAQNNDILLLIAAPED
VANQSLDHLRRLIAKERNFYNEAQYNFVWITDFPLFAKEDGKICSEHHPF
TSPLDEDIPLLDKDPLSVRSSSYDLVLNGYEIASGSQRIHNADLQNKIFS
ILELSPESIKEKFDFFIDALSFGTPPHLGIALGLDRIMMVLTGAEGIREV
IAFPKTQKAADLMMDAPAEIMTSQLKELSIKVTS
>CAB307 def, peptide deformylase
MIRELEYYGSPTLRRKAEAILEITDEIRQLAQDMYETMVAHKGVGLAAPQ
VGESVSLFVMCVEGETEDGDLIFCDFPKVYINPVLSNVSEDLVLGREGCL
SIPGLRADVYRPRSITVKAINLDGQEFTEHLEGFPARIVMHENDHLNGIL
YIDKMEEPKDYKKFKSALEKIRRRYNNHITDKAS
>CAB839 efp, elongation factor P
MVRVSTSEFRVGLRIEIDGQPYLILQNDFVKPGKGQAFNRIKVKNFLTGR
VIEKTFKSGESVETADVREQQMRFLYSDQEGATFMDDKTFEQEVIFWDKI
ENIRQWLLEDTIYTLVLYNGNVIAVEPPIFMELTIAETAPGVRGDTASGR
VLKPAVTNTAAKIMVPIFIEEGEVVKIDTRTGSYESRVSK
>CAB193 epmA, 50s ribosomal protein l27
MAHKKGQGASRNGRDSESKRLGMKVGAGQRVSTGSILVRQRGTKWHPSKN
VGRGRDDTLFALIDGIVVTRKTDRTYISVLPE
>CAB091 fmt, putative methionyl-tRNA formyltransferase
MSLKIVYFGTPQFAATVLADLLHHEVNVVAVVTRVDKPQKRSSQLIPSPV
KTLALSKNIPLLQPEKVSDPQFVEQLRDFEADVFIVVAYGAILKQMVLDI
PKYGCYNLHAGLLPAYRGAAPIQRCIMDGVVQSGNTVIRMDAGMDTGDIA
NVSFVPVGPDMTAGELAEALASQGGEILIKTLQQISDGTITHTPQEASKA
SIAPKLSKEEGFILWDHPAEKVYAQIRGVTPAPGAWTLYSYQGKPARRLV
IRKASLSSSQGVYGHPGDILLSDQQELLVACAEGAICLKEIQPEGKGVMD
SKSFLNGHSGHKLKLSLNLMS
>CAB286 gatA, glutamyl-tRNA amidotransferase subunit A
MYQKSALELRNAVVSGESSATAIAKYFYNRIKTEDNQIGAFLSLCEERAY
EKAAIIDAKVARGEPLGKLAGVPIGIKDNIHIRGLRTTCASKMLENYIAP
FDATVVERIEAEDGVILGKLNMDEFAMGSTTQYSAFHPTKNPWGLSCVPG
GSSGGSAAAVSARFCPIALGSDTGGSIRQPAAFCGVVGFKPSYGAVSRYG
LVAFGSSLDQIGPLTTVVEDVALAMDVFAGKDDRDATSQKFFTGSFQEAL
SLDVPSLIGVPMGFLDGLRDDVKENFFASLSILERQGSRIVEVDLNILDH
AVSVYYIVASAEAATNLARFDGIRYGYRSPEAHSIEDIYTISRVQGFGKE
VMRRILLGNYVLSTERQNVYYKKGSAIRAKIIQAFQKAYEKCDVIAMPVC
SCPAFADGEILDPTSLYLQDIYTVAMNLAYLPAIAVPSGFSREGLPLGFQ
VIGQKGKDQQVCQVGYSFQEHSGIKNLYPKGCNKLVDGEVK
>CAB287 gatB, aspartyl/glutamyl-tRNA amidotransferase subunit B
MSDVYADWESVIGLEVHVELNTKSKLFSCARNRFGDEPNTNISPVCTGMP
GSLPVLNKEAVRKAVLFGCAVEGEVALLSRFDRKSYFYPDSPRNFQITQF
EHPIVRGGHIKAIVHGEERHFELAQAHIEDDAGMLKHFGEFAGVDYNRAG
VPLIEIVSKPCMFCADDAVAYATALVSLLDYIGISDCNMEEGSVRFDVNI
SVRPKGSEELRNKVEIKNMNSFAFMAQALEAERCRQIDAYLDNPNADPKT
VIPGATYRWDPEKKKTVLMRLKERAEDYKYFIEPDLPVLQLTEAYIDEIR
HTLPELPFNKYQRYLHEYALAEDIAAILISDKHSAHFFELAAQECKNYRA
LSNWLTVEFAGRCKLKGKNLAFSGILPSSVAQLVNFIDQGVITGKIAKDI
ADMMMESPEKSPETILKENPEMLPMTDESALVAIISEVITANPQSVVDYK
SGKTKALGFLVGQIMKRTQGKAPPNRVNELLLVELSK
>CAB285 gatC, glutamyl-tRNA amidotransferase subunit C
MTQPYVTREDIILLAKSSALELSEEFIQEYESSLNEVIKTMAASIAMDVT
DVVIEVGLSHVISPEDLREDIVASSFSREEFLTNVPESLGGLVKVPTVIK
>CAB179 gltX, putative glutamyl-trna synthetase
MAWENVRVRVAPSPTGDPHVGTAYMALFNAIFAKRFNGKMILRIEDTDQT
RSRDDYEKNIFSALQWCGIQWDEGPDIGGPYGPYRQSERTEIYRKYAELL
LKTDYAYKCFATPKELEEMRAVATTLGYRGGYDRRYRYLSSEEVDARTRE
GQPYTIRLKVPLTGECVLDDYCKGRVVFPWADVDDQVLIKSDGFPTYHFA
NVVDDHLMGITHVLRGEEWLSSTPKHLLLYQAFGWKAPTFLHMPLLLNPD
GTKLSKRKNPTSIFYYRDAGYIKEAFMNFLTLMGYSMEGDEEIYSLEKLI
ANFDPRRIGKSGAVFDTRKLDWMNKHYLTHERSSESLLAKLKDWLINDEF
FLKILPLCQSRITTLAEFIGFTGFFFSVLPEYSKEELLPTTISQEKAAIL
LYSYVKYLEKSDLWVKDQFYQGSKWLSSAFQVHHKKVVIPLLYVAITGKK
QGLPLFDSMELLGKPRTRARLVHAQNLLGGVPKKIQTTIDKVLKEEDLES
KIFEF
>CAB792 glyQ, glycyl-tRNA synthetase alpha chain
MSPPLTLQAMIAKILQFWSEQGCVIHQGYDLEVGAGTFNPATFLRAVGPE
PYQTAYVEPSRRPQDGRYGTHPNRLQNYHQLQVLLKPVPTNFLSLYKDSL
QMIGLDLREHDVRFVHDDWENPTIGAWGLGWEVWLNGMEITQLTYFQAIG
SKPLDTISGEITYGIERIAMYLQKKNSIFDVLWSDELTYGDVTRASEKAW
SEYNFDAANTQMWLKHFEDFAQEALAVLDKGLPVPAYDFVIKASHAFNIL
DARGVISVTERTRYITRIRQLARAVADGYVDWRASLNYPLLRNRKADENV
DTQILPCPKIETAKNFLLEIGSEELPATFVPMGIQQLESLAKKLLSDYNI
GYDSLEVLGSPRRLALLIYNLEPTAIQKASEKKGPVLSSLFSHSGDVTTQ
GEQFFATHHAHIRHYSELAQYSLFDIREVQGVRYLFLLYPEVRKDTAAIL
SNELPKLIQSMKFPKKMTYDDSGVEYARPIRWLVSLYGTSVVPFSFGKVS
ASNISWGHRQLDPREVQIPSCERYVDTLRDACVIVSHKERREIIEQGLKS
HSSDNVSPITNPRLLEETVFLTEHPFVTCGQFDPEFCSLPKELLIAEMVN
HQKYFPTQNRAQQITNQFILVCDNCPNDIIIQGNEKALTPRLTDGAFLFA
QDLKTPLTTFVDKLKSVTYFEALGSLYDKVQRLKAHKKIVYPLLPLSSEE
DINTAIEFCKADLVSAVVNEFAELQGIMGEYYLKHAGLSHASAVAIGEHL
RHITYGQTVSTTGTLLSLLDRFDNLLSCFILNLRPTSSHDPYALRRQSLE
ILTLLHASEISLDLESLLYHLADNFPSTVEGTSWDKPAVIKDLLAFIWGR
LKTFLASLGFSKDEIATVLSDTSEKNPVEIIKSATAIQDMKAHQGAALEK
ITTTHNRLKKILASLKLSTHKHTPMELDLQEARLQAALDRFDASANIKNK
KDYFLCLGELTDDINTFLNEVHVTSGSEELKNLRIHLLVMAMEKFSSYHW
ESLKN
>CAB078 hisS, putative histidyl-tRNA synthetase
MKVALPKGVFDIFPYITDAKHMWRHTSLWHRVEDVIHDVCGLYGFSEIRT
PVFEKSEVFLHVGEQSDIVKKEMYTFLDKKGRSLTLRPEGTAPIVRSFID
NSMNQRDDNKFYYILPMFRYERQQSGRYRQHHQFGVEAIGVRHPLRDAEI
LALLWHFYSAVGLQHMQVQLNFLGGEVTRKRYDKILREYFLDHLSSLSLL
SKERFNTNLLRILDSKEPEDQEIIQSAPPILDYVSDDDRKYFDEILSALD
ALNIAYDINPRLVRGLDYYTDLVFEAITTCRDHSYALGGGGRYDGLIASS
GGPATPACGFGIGLERVIQTLLAQGNFTPLSSHKLRLIPVESQADSFCFV
WAQHLRSLGIPTEVDWTHKKLKNALKIADAEKATFVCPVGERELVSEQLT
VKNMSLRQEFSGSKQEVEQRLLYEIQNTSL
>CAB634 ileS, isoleucyl-tRNA synthetase
MHTEGEGSKESLASREERILNFWKTQEIFQKSLKNREGRTLYSFYDGPPF
ATGLPHYGHLLAGTIKDVVGRFATMDGYYVPRRFGWDCHGVPVEYEVEKS
LNLTTPGAIEDFGVAKFNEECRKIVFRYVDEWEHYIYRVGRWVDFSATWK
TMDASFMESVWWVFRSLYDQGLVYEGVKVVPFSTKLGTPLSNFEAGQNYK
EVDDPSVVIKFALHGDPGSLLVWTTTPWTLVSNMAVAVGPEITYVRVADK
VSGEQWILGQGCLSRWFSDPDTYEVIESFPGTALIGKSYEPPFNFFEQKR
AEGAYTILPGSFVEESEGTGVVHMAPAFGEADFFVCKEHHVPMVCPVDNH
GCFTEEIPEYQGQYIKSCDKGIIKSLKNQGKVFYHGTVVHRYPFCWRTDT
PLIYKTVNSWFISVEKIKDKMLQANKKIHWVPEHIKEGRFGKWLEGARDW
AISRNRYWGTPIPVWKSKDGDILVIGSVEELEKLTGEKVSDLHCHFVDQL
KIEKDGKSFHRVPYVFDCWFDSGAMPYAQNHYPFENQKETESGFPADFIA
EGLDQTRGWFYTLTVISAALFDQPVFKNAIVNGIVLAEDGNKMSKRLNNY
PSPMSIMNTYGADALRLYLLDSVVVKAEDLRFSDKGVESVLKQVLLPLTN
VLSFFKTYTDLYGFDANNYDKEEISYSEIDRWILSNLYTVVGKVRESMSS
YNLNTAVNPFVTFIDDLTNWYIRRCRRRFWESADTPDRRAAFATLYEVLT
VFCRVIAPFIPFISEDIYQQIKTENSLESVHLCDFPYIDLAKVFPDLEQR
MGDAREIVGLGHSLRKEHKLKVRQPLANFYVVGPKDRLDQLDSFKQLISE
ELNVKNIVFYKEAPSFVKTTVKPNFRSLGRRVGEKIKDIQKALASLSQAQ
IQQLLTQEYLSLNLGSEEIVLHMEDVLISWETDPGYVARSSSLFTVVLDC
QLTEELVVEAISRELVNKINTMRRNQKLHVSDRIVLRMQTSEEVRKAFLH
YADYICEETLTTQSEFADVLEGEEWDINGHPTVIAIEVAARPH
>CAB451 infB, translation initiation factor
MKIKNAQLTKAAGLDKLKQKLAQAGSSDTKSSSEKPTTKVPEKVAKEKVV
KKKSVLDSSVPTMAEHVSTETSPRRIRAKNRSSFASEDSTIPSPVSVDTE
STAFSPPVVEEVVSPLESAEPEIVEPTPASIVDEPETTIQEPPPPKKEAE
LVVKKEPPKNVVSIKSNFGPTGKHINHLLAKTFKAPKKEDKPAPKERTGT
VQTKPQQSSEVPSDKQHSSNNRQSQPFYRRDTSKRPGSDFRDRSKKDDSP
KAFTGRDRYGLNDSSDDDKWRKKRVQKTKKHYDEHSVQRPTHIKVPLPIT
IKDLAAEMKLKASELIQKMFIHGMTYVVNDVLDNETTVQFIGLEFGCTID
IDSSEQDKLCIESNTVKEEIQETDPSQLIIRPPIVAFMGHVDHGKTTLID
SLRKSNVAAVEAGAITQHMGAFCCSTPVGNITILDTPGHEAFSAMRARGA
EVCDIVVLVVAGDEGIKEQTLEAVKHARAANITIVVAINKCDKPNFNADT
VYRQLSEINLLPEAWGGTTVTINTSAKTGEGLSELLEMLALQAEVLELKA
NPEARARGIVIESELHKGLGAVATILVQNGTLHLGEALVFNDCYGKVKTM
HNEHNQLMTSASPSVPALITGLSSMPKAGDPFVVVKNEKTAKEIVNARIA
GQQKFALQKKRPNFDAMLQNKKILKLIIKADVQGSIEALSSSVLKIVSDK
VSAEILSSSVGEISESDIRLAAASKAVIIGFHTGIESHAESLIKNLGVKV
HLFNIIYHAVDAVKEMMTALLDPIAEERNLGSAEIKETFKSSQLGTIYGC
LVSEGVMTRNQKVRVVRNNEVLWKGNLSSLKRIKEDVKEVKKGLECGILL
EGYQNAQVGDILQCYEVIYHPQKL
>CAB739 infC, initiation factor IF-3
MNRQIRAPKVRLIGSAGEQLGILNTKDALDLARESDLDLVEVASNSEPPV
CKIMDYGKYRYNLTKKEKDSKKAQHQVRVKEVKLKPNIDDNDFATKLKQA
RGFIEKGNKVKITCMFRGRELAYPEHGYTVVQKMSQGLEDVGFIESEPKL
NGRSLICVVAPGTVKTKKKQDKINAQDEKQ
>CAB300 ksgA, dimethyladenosine transferase
MSRSSPEQLSRFLAEVHGRPKKGLSQNFLIDGNILRKILAVSCVQAGDWV
LEIGPGFGALTEVLVNQGAHVVALEKDSMLEETLKQLPIHLEITDACKYP
LSQLQDQGWQGKGRVVANLPYHITTPLLRKLFLEAPNQWKTVTVMIQDEV
ARRITAQPGGKEYGSLTIFLQFFVDVHYAFKVSPGCFLPKPQVASAVVHM
TVKENFPLEEPLRTKFFSLTRAAFGQRRKLLANALKDLYPKERVFEALSQ
LHFSDKTRPETLSLDDYLKLFYLLSLPA
>CAB585 leuS, putative leucyl-tRNA synthetase
MRYDPSLIEKKWQQFWKEHKSFKADETADKPKYYVLDMFPYPSGAGLHVG
HLIGYTATDIVARYKRAKGFSVLHPMGWDSFGLPAEQYAVRTGTHPRETT
KKNIENFRKQLSAMGFSYDEAREFATSDPEYYRWTQKLFLFLYEKGLAYM
ADMAVNYCEELGTVLANEEVENGLSIEGGYPVERRMLRQWILRITAYADQ
LLQGLEDLDWPENVKQLQRNWIGKSEGALLRFVVDKDKCLEVFTTRPDTL
CGVSFLVMAPEHPEIQQLVSEEQRSAVESYIRCAQSKSERERISETKVKS
GVFTGAYAKHAITGAALPIWVSDYVIMGYGSGVVMGVPAHDERDREFANA
FALPIDEVLDENEHCINSNHGDFLLNGLQGKEASDYVIAYLQKRNLGEAK
VMYKLHDWLFSRQRYWGEPIPIIHFEDGTCRPLEDDELPLLPPEIQDYRP
KGFGQGPLAKVKEWVDIHDVKTQRPGRRETHTMPQWAGSCWYYLRFCDAH
NSQAPWSHENERYWMPVDLYIGGAEHAVLHLLYSRFWHRVFYEAGLVSTP
EPFKKLINQGLVLATSYRIPGKGYVHPEDAREDNGKWTTASGEELEVRQE
KMSKSKLNGVDPQILIDEFGADALRMYAMFSGPLDKNKLWCNQGVSGCRR
FLNRFYELATSSAVQDIDDPKGMALAHRLVHKVGEDIEKMSLNTIPSSFM
EFINEFAKLDTYSKSALSMVVRALAPIAPHISEELWTVLGYAPGIDNAGW
PEVDPKYLEDTSVTFVIQVNGKLRARLDMDKNTSQEDILSAARESVAKYL
EDKEIKKEVFVPNRLVNFVL
>CAB622 metG, methionyl-tRNA synthetase
MPSRVLITSALPYANGPLHFGHIAGAYLPADVYARFRRLLGDDVLYICGS
DEYGIAITLNAERAGMGYQEYVNMYHKIHKDTFDKLGISIDFFSRTTNPF
HKKLVQDFYTELQSKGLIENQISLQLYSEEENRFLADRYVEGTCPKCGFD
GARGDECQKCGADYEATDLVHPRSKLSGSQLVLKETEHAFLHLERMVEPL
LAYIDTCYLPEHIRKFVTDYIKNLRPRAITRDLSWGIPVPDFPNKVFYVW
FDAPIGYISGTMDWAASLNTPEAWKDFWLEDSTEYVQFIGKDNIPFHAAI
FPAMELGQSIPYKKMDALVSSEFYLLEGCQFSKSEGNYIDIDTFLDTYSL
DKLRYVLAATAPETSDSEFTFMDFKTRCNSELVGKFGNFIHRVLVFAEKN
GFKELAYSANLLEDQDKQFLDRAQQIVRDAQEHYSQYSLRKACCAIMELA
ALGNVYFNDQAPWKLLKEGLSHRVEAVLFCACYCQKLLALISYPIIPGTA
WEIWRMLSPKSLQLDSLDKDRVVDLWNRELLNFSEEVFSLTAPQLLFTIV
D
>CAB736 pheS, phenylalanyl-tRNA synthetase alpha chain
MAIQEELEATKQQFCAELSQVNSSKDLFDLKVRYLGKKGLFRCFADKLRE
CPADQKALMGASINDCKTYIENLIRDKNHAILLAEEAAEFLREKIDITLP
GEPHCPGGKHIVKKVLDDVVDIFVHLGFCVREAPNIESEENNFSLLNFEE
DHPARQMHDTFYLDPKTVLRTHTSNVQVRELRKGQPPIKVVAPGLCFRNE
DISARSHVIFHQVEAFYLDRYVTLSDLTAMLTEFYHTFFEREIELRLRHS
YFPFVEPGIEVDVSCECRQAGCSLCKHTGWLEVAGAGMIHPQVLRNSGFD
PEIYTGYAVGMGIERLAMLQHGISDIRLFCENDLRFLQQFS
>CAB730 pnpA, polyribonucleotide nucleotidyltransferase
MTFETISVTLEEGKTLVFETGKIARQANGAVLARMQETWVFSSVCAANLE
EAVDFLPLRVDYQEKFSSIGKTLGGFIKREGRPTEREILTSRLIDRSMRP
SLPNRLMQDIQILSYVWSYDGVTLPDPIAICGVSAALAISDIPQTSIVAG
VRVGFVNNRWVVNPTKAEMDVSRMELVLAGTENAILMIEGHCDFFTEEQV
IEAIEFGHKHIVTICKALKDWQKHIGKEKNTSGIVSLPEEVQSAVNTFVE
GKFVDLLKIKEKKAFEAASKQLENEVIEQLQEENEVFTAFNIKIAFKQAK
SNFIRGLIREQGLRSDGRSVTTIRPISIDTSFLPRTHGSCLFTRGETQTM
AVCTLGSEAMAQRYEDLNGEGLAKFYLQYFFPPFSVGEVGRIGSPGRREI
GHGKLAEKALSHTLPDPMKFPYTIRIESNITESNGSSSMASVCGGCLALM
DAGVPIKTPIAGIAMGLILEDDHVTILSDISGLEDHLGDMDFKVAGNTEG
ITAFQMDIKVEGITPDIMRAALAQAKEGRQDILETMKQALAAPKTDLSQY
APRIETMQIKPNKIATVIGPGGKQIRQIIEEAGVQIDINDSGLVSISASS
PQAIEKAKSIIEGLVGEVEVGKIYEGRVTSVVPFGAFVEILPGKEGLCHI
SEFSKQRIDNVGDFVKQGDTLTVKLLSINEKGQYKLSHKATLSE
>CAB630 prfA, peptide chain release factor 1
MQKKILEYLKRLEEVEVEISNPEIFNNPKEYSLLSKEHARLSELKNTYDR
VMAQEKVLSDDKQALAQEKDPEMIAMLEEGIQSGKAEVEKLYKILENLLV
PPDPDDDLNVIMELRAGTGGDEAALFVGDCVRMYHLYASAKGWKYEVLSA
SESDIGGYKEYVMGISGTGVKRLLQYEAGTHRVQRVPETETQGRVHTSAI
TVAVLPEPAEDDEEVFIDEKDLKIDTFRASGAGGQHVNVTDSAVRITHLP
TGVVVTCQDERSQHKNKAKAMRILKARIRDAEIQRRHKEASAMRSAQVGS
GDRSERIRTYNFSQNRVTDHRIGLTLYSLDKVMEGDLDTITSALVSHAYH
QLLQNGNEENS
>CAB163 prfB, putative peptide chain release factor 2
MHESLDKRLEGLLTGLALAGRSLDLEGKRQELSILEEQTLKEDFWQDVTS
AGKVSERIVSLKRQIAHYEEFKVRVENLAFFLNDGDVSADPELREDLEKE
FTICEHILSEWETQRLLSGEVDKNPCFLTINAGAGGTESCDWVEMLFRMY
CRWAAQHQWKVEVIDRQEGDVAGIKHVTVKFSGDYAYGYAKAERGVHRLV
RISPFDSNAKRHTSFASVDVYPEIDDEIEIDIRPNDLRIDTFRSSGAGGQ
HVNVTDSAVRITHIPTGIMVSCQRERSQIQNRESCMKMLRARMYQQILQE
RLEKQLLDRKNKKEIAWGSQIRNYVFQPYTLVKDVRTGHETGNVQAMMDG
ELLDDFVKAYLAEYGEIS
>CAB240 proS, prolyl-tRNA synthetase
MKTSQLFYKTSKNANKEASVLSYELLEKAGYIFKTAKGIYTYTPLFWRVA
LKMMDIIREELNAIGGQELVLPILHPAELWQKTGRWEAFRSEGLLYTVKD
REDKEFCLAPTHEEIVSMFVSQWLSGRKQLPIHLYQIATKFRDEIRPRFG
LMRAKEFLMEDSYTFSDSPEQMNEQYAKLRQAYQNIFDRLEIQYVIVEAD
GGKIGKGKSEEFHVLSSLGEDTLCVSGHYGANIEAAVAQPPQYTYDKDYL
PIEEVDTPDVRTIENLQDFFSVPPYRIMKTLVVKLSYGEKEKFTAIGIRG
DRQINLTKIGSKLNADACSLASDEEIQKHLGVEKGFIGPLNCPIDFYADE
TTQCMTNFICAGNVKDKHYKNVNWDRDIPRPEYADFLLAEAGDLCPTNNH
APYEIFEGVEVAHIFNLGTRYTEGFDVVFQDEQGKPQSCWMGTYGIGIGR
TLAACIEQLADDRGIVWPKAIAPFDISILYNGGDTACEEAAEKIYKELQG
YGYAPLLDDRNERLGFKLKDSDLIGIPYKLILGKTFLNSGMLEIESRSIE
KFSVEPKDFVHWCKRHLPSPRVFSPIP
>CAB788 pth, peptidyl-tRNA hydrolase
MTSLVVAIGNPGRQYVWTRHNVGFLCVDRLVQQFPGVHFKEAPKLFSDIA
KVESSQGSMVFIKPRTYVNLSGKAVLAVKGYYNIATDRILVIADDVNQPF
GNVRLRQSAGGGGHKGIKSITQSLGSNDYWQLRLGIGRPQRENVELSDFV
LGQFTEEEQIGIQSVFIEASALFSQWCSGTQTA
>CAB450 rbfA, ribosome-binding factor A
MTENRRIKKVNSLLREAIANVILKDVKHPKISNRWITVTRVCLSKDLHSA
RVYVSIMPHENTSTETLEALKASARYIAYKASKGVVLKYFPEINFYLEDI
FSPQDHIENLLWKIREQDKN
>CAB871 rluB, putative 16S pseudouridine synthase
MGKIRLNKFLASSGVASRRKCDEIIFSGHVTVNGRVAPGPFVLVDEETDT
VKVDGRRVGMTKKVYFMVHKPLGYLCSSERTFPGDKLVIDLFSHLPYRVF
TVGRLDKETSGLILVTNDGEFSNKIIHPSFGITKEYLLKVSRDVTAKNLE
DLMEGTVIDGKRVRPVSVEKIRRGTLKIIVNEGKKHEIRLFAEAAGLPIL
ELSRIRIGSFVLGGLRYGEYRELTDAEILTYM
>CAB379 rluC, ribosomal large subunit pseudouridine synthase C
MEEFSWVAQHEERLSSFLRSRLPDYKKHIIMDSVRYHGCRVNGRVERFES
YRVQPGDRITLTVQTRLEPQILWEDAHCCIYNKPSHTSTEDLAKITRLNI
VHRLDRDTTGCILFAKHASAANALSELFKKRKIHKQYTALVFGHPKKSSG
TVISYTAPKSRRCGSVIFGNTPKNQGKLTITQWSILRTYKQYTLMRCEPI
TGRTHQIRLHMQTLGHPIVGDVDYGRKEQPKHVFRPLLHAHALTFTSPFS
KEKVAVTASTSGDPREEAPHLLIN
>CAB023 rluD, putative pseudouridine synthase
MQSNTPLFFIVNETNRDRLDKFLVSQNPKYSRAFYQQHIVDQRVTINEQI
QTKVSTQLVPGDTVSITIEEKEEPSELLPEAIPLEKIYEDEMILVINKPR
DMVVHPAPGHTRGTVVHALLHEIGERLKQEFPEEPWRPGIIHRLDKDTSG
LLITAKTRQAKMIYSELFATKQLKKSYLAICVGKPSASVIHTKLARHHTK
RKEMAVSSTGKEAITRCEVLAYNGKFSLVLLHPETGRTHQLRVHMKHLST
PILGDPVYGSASANSCYGLDKQQLHAYSVNFIHPQTHKHLNLTTELPRDM
KILIIKEFYNSKTVINKQLFESIIK
>CAB664 rplA, putative 50S ribosomal protein L1
MTKHGKRIRGILKSYDFSKSYSLQEAIDILKQCPPVRFDQTVDVSIKLGI
DPKKSDQQIRGSVSLPHGTGKTLKILVFAAGEKAKEALDAGADFVGSDDL
VEKIRGGWVDCDVAVATPDMMREVGKLGKVLGPRNLMPTPKAGTVTMDVT
KTIAELRKGKIEFKADRAGVCNAGVGKLSFDGHLLKENIETLCSALIKAK
PPAAKGQYLVSFTVSSTMGPGISVDTRELMAS
>CAB096 rplB, putative 50S ribosomal protein l2
MFKKFKPVTPGTRQLVLPAFDELTTQGELSGKKTRKSVRPNKKLSFFKKS
SGGRDNLGHISCRHRGGGAKRLYRVIDFKRNKDGIEAKVVSVEYDPNRSA
YIALLSYADGEKRYILAPKGIKRGDQVISGEGSPFKLGCCMTLKSMPLGS
TVHNIEMRPHSGGKLVRSAGLAAQVIAKTPGYVTLKMPSGEFRMLNEGCR
ATIGEVSNSDHNLCVDGKAGRKRWKGIRPTVRGTAMNPVDHPHGGGEGRH
NGYIPRTPWGKVTKGLKTRDKRKSNKWIVKDRRK
>CAB093 rplC, putative 50s ribosomal protein
MQSQLSLMGKKEGMIHVFDKDGNLVACSVISMSSNVVTQIKVDSTDGYNA
IQMGANEINVPEKTLHKRVNKPSIGHFKKSGSRVFRELKEVRLSEEAVNE
VSLGSEFGLEVFESVSSIDVSGVSKGKGFQGVMKRFGFRGGPQSHGSGFH
RHAGSIGMRSTPGRCFPGSKRPSHMGTVNVTVKNLEVIKIDLEKKVLLVK
GAIPGPRGSVVVVRRSSRAKG
>CAB094 rplD, putative 50S ribosomal protein l4
MVLLSKFDFFGNKAGEVELPDAFFAQEGSGLQLVKDYLVAIRANKRQWSA
CTRNRSEVSHSTKKPFRQKGTGNARQGCLAAPQFRGGGIVFGPKPKFDQH
VRINKKEKRAAIRLLLSQKIQTNHLIVADDSVFTNSLTSPKTKEALRFLK
SCNVECRGVLFIDDLEHAQNNESLRLSLRNLPAVRGFTYGMNINGYDLVS
ARNIVISEKALNRLSGHLISAMKD
>CAB104 rplE, putative 50S ribosomal protein l5
MSRLKKLYTEEIRKTLQEKFGYSNTMQIPVLKKIVISMGLAEAAKDKNLF
QAHLDELSMISGQKPLVTKARNSIAGFKLREGQGIGAKVTLRGQRMYDFM
DRFCHIVSPRIRDFRGFSSKGDGRGCYSLGLDDQQIFPEVDLDRVKRTQG
MNITWVTTAQTDVECTTLLELMGLRFKKAQ
>CAB106 rplF, putative 50S ribosomal protein l6
MSRKARDPIVLPQGVEVSIQNNEILVKGPKGSLKQVLAPEVVIDIKGREV
FVHPAPYVVDRPSRMQGLFWALISNMVQGVSVGFEKRLEMIGVGFRASVQ
GSILDLSIGVSHPTKIPIPADIQVSVEKNTIISVKGINKQLVGEFAANIR
AKRKPEPYKGKGIRYENEYVRRKAGKAAKTGKK
>CAB785 rplI, 50S ribosomal protein L9
MKQQLLLLEDVEGLGRSGDIVTARPGYVRNYLLPKQKAVIAGAGTLRLQA
KLKEERLLRAAADREESEKLAQILKDIVLEFQVRVDPDNNMYGSVTVSDI
IAEAAKKNIVLTRKNFPHAHYAIKNLGKKSVPLKLKEDVTATLIVEVSSE
SSYVAVLNPQPSQEQTAAEELN
>CAB663 rplJ, putative 50S ribosomal protein L10
MKEEKKLLLREVEEKISASQGFILLRYLGFTAAHSREFRNSLSGVSAEFE
VLKKRIFFKAMQSAGFDIDSSDTSGHLGVVFAYDDAVSAAKQVLDFNKQY
NDSLVFLAGRIDSANLSGKEVEAVAKLPSMKELRQQIVGLLAAPMSQVVG
IMGSALSGVISCIDQKTQKN
>CAB665 rplK, putative 50S ribosomal protein L11
MSNKKVIKLIKLQIPGGKANPAPPIGPALGAAGVNIMGFCKEFNAATQDR
PGDLLPVVITVYSDKTFTFITKQPPVSSLIKKALNLESGSKIPNRNKVGK
LTQAQVTAIAEQKMKDMDVVLLESAKRMVEGTARSMGIDVE
>CAB662 rplL, putative 50S ribosomal protein L7/L12
MTKVTTQSLETLVETLSSLTVLELSALKKLLEEKWDVTAAAPVMAVAAGA
AGAGAEAAPAESTEFAVTLEEVPADKKIGVLKVVREVTGLALKEAKEMTE
GLPKVVKEKTSKSDAEETVKKLQEAGAKASFKGL
>CAB518 rplM, 50s ribosomal protein l13
MEKRKDTKTTIAKASEAQNKSWYVIDAAGKTLGRLSSEVAKILRGKHKVT
YTPHVAMGDGVIVINAEKVHLTGAKKGQKIYRYYTGYISGMREVAFENMI
AKKPSYIIEHAIKGMMPKTRLGKRQVKSLRILKGDYYQEFKSQKPIVLDV
>CAB102 rplN, putative 50S ribosomal protein l14
MIQQESQLKVADNTGAKRVKCFKVLGGSRRRYATVGDVIVCSVRDVEPDS
SVKKGDVVKAVIVRTRRNILRKDGSSLKFDTNSCVIIDEKGNPKGTRIFG
PIAREIRDRGFVKISSLAPEVI
>CAB109 rplO, putative 50S ribosomal protein l15
MIKLESLQDPSPRKRRTKLLGRGPSSGHGKTSCRGHKGDGSRSGYKRRFG
YEGGGVPLYRRVPTRGFSHARFDKCVEEITTQRLNALFSEGEEITLEALK
QKKAIDKRAIRVKVIVKGDLEKTFIWKDANVVLSQGVRNLIGVA
>CAB100 rplP, putative 50S ribosomal protein l16
MMPKRTKFRKQQKGQFAGLSKGATFVDFGEFGMQTLERGWVTSRQIEACR
IAINRYLKRRGKVWIRIFPDKSVTKKPAETRMGKGKGAPDHWVAVVRPGR
ILFEVANVSREDAQDALRRAAAKLGIRTRFVKRVERV
>CAB114 rplQ, putative 50s ribosomal protein l17
MQHARKKFRVGRTSAHNRCMLANMLKSLIHQERIETTLPKAKELRRHADK
MITLAKKNTLAARRLAVARLMIRYNKLTSKEARQAKGGDLSVYNVDRKVI
NKLFDELGSRFVSRNGGYTRILKMQNRVGDNARKCIIEFLAN
>CAB107 rplR, putative 50s ribosomal protein l18
MENSLFKKSEKKVRRALRVRKVLRGSSLKPRLSVVKTNKHIYVQLIDDSI
GKTLASVSTIAKSSKAAGLVKKNQGVAKALGVQIAEIGKSLQVDRVVFDR
GPFKYHGIIAMVADGAREGGLQF
>CAB626 rplS, 50S ribosomal protein L19
MGNLIKELQEEQLRKEILTDFCVGDTIRVATKIVDGGKERTQTFQGTVMA
RKGGGAGEVISLHRVAYGEGMEKSFLLHSPKIVGIEVVKRGKVSRARLYY
LKGKTGKAAKVKEYIGPRSAKK
>CAB737 rplT, 50S ribosomal protein L20
MRATGSVASRCRRKRILKQAKGFWGDRKGHFRQSRSSVMRAMAFNYMHRK
DRKGDFRSLWIARLNVASRINGLSYSRLINGLKCAGIDLNRKMLSEMAIH
NPTGFAEVANQAKKALEANL
>CAB192 rplU, putative 50s ribosomal protein l21
MKSYAIIQTGSKQYQVSEGDIIDVELLDGVSEGQEIVFDQVLFTFDGSKV
SLGTPTVKNAVVKGELLSRVRGEKVIAYKYKRRKNYHRKIGHRQNYLRVK
ISNLVM
>CAB098 rplV, putative 50S ribosomal protein l22
MFKATARYIRVQPRKARLAAGLMRNLSVTEAQQQLSFSQLKAGRCLKKVL
DSAVANAELHDNVKREKLNVIEVRVDAGPVYKRAKSKSRGGRSPILKRTS
HLTVIVGEKER
>CAB095 rplW, putative 50S ribosomal protein l23
MKDPYDVIKRHYVTEKAKTLEGLSLGNGEGKKKGSYCKHPKYTFIVDSNA
TKPLIAQALESIYADKKVKVKSVNTICVKPQPARMFRGKRKGKTAGFKKA
VVTFYEGHSIG
>CAB103 rplX, putative 50S ribosomal protein l24
MKRRSVCVGDTVYVLAGNDKGKQGKVLSCLREKNKVVVEGVNVRTKNIKR
SQENPKGKRINIEAPIHISNVRLSIDGAPAKLSVKVTENGRELWNKSSDG
TSKLYRSVKERKG
>CAB789 rplY, putative 50S ribosomal protein L25
MELVVTSRETDKKSLLKKIRQTGGIPAVIYSGGKSLANIVVDAHVFSKFL
SSLESGALSSTIFSLSYEGRTIKALVKDIQYHVTSYRVIHLDFEELIEDR
DVKLKIPIRCINAVDCVGVKLGGSLRQVIRALRVVCKPKDIVPYLELDVR
SLGLSQTRKLSDIQIPAGLRPITPLKEVAVTVSRR
>CAB441 rpmB, 50s ribosomal protein l28
MSRKCPLTGKRPRRGNSYTIRGIAKKKKGIGLKVTGKTPRCFFPNMVTKR
LWSTEENKFLKLKISASALRLINKLGLEKVIARAKNKSL
>CAB100A rpmC, 50s ribosomal protein l29
MSVKKKLLAELRQKSLVELDAFIHENKKALFSLRAEAALQNKAVKTHLFS
MYKKTIARSMTVKQEKEGKVDG
>CAB631 rpmE, 50S ribosomal protein L31 type B
MKKNTHPNYQQVLFVDSSTGYKFVCGSTYQSDKTEVFEGQEYPVCYVSVS
SASHPFFTGSKRLVDAEGRVDKFLKRYSNVKPAQPAQAAVEEAPAVKSKK
KAPIKKKK
>CAB778 rpmF, 50S ribosomal protein L32
MAVPRNRHSNARKNIRRSHHAKQARHAAVCNNCKQAFIPHTVCTSCGFYN
GKAVMTVEKK
>CAB513 rpmG, 50s ribosomal protein l33
MASKNREIIKLKSSESSDMYWTVKNKRKTTGRLELKKYDRKLRRHVIFKE
AK
>CAB738 rpmI, 50S ribosomal protein L35
MPKMKSNKSVAARFKLTGSGQLKRTRPGKRHKLSKKSSQEKRNLSKQPLV
DKGQVGMYKRMMLV
>CAB803 rpmJ, ribosomal protein L36
MKVSSSIKADPSKGDKLVRRKGRLYVINKIDPNRKQRQAGPARKK
>CAB453 rpsA, 30s ribosomal protein S1
MPKQSEYTWGSKKILDTIDCLSEDVVEFKDLLCSTHGITSSDEEPTSEIQ
PGAILKGTVVDINKDFVVVDVGLKSEGVIPMSEFIESSEGLVLGAEVEVY
LDQTEDEEGKVVLSREKATRQRQWEHILAHCEEGSIVKGQIIRKVKGGLI
VDIGMEAFLPGSQIDNKKIKNLDDYVGKVCEFKILKINIDRRNVVVSRRE
LLEAERISKKAELIEQITIGERRKGIVKNITDFGVFLDLDGIDGLLHITD
MTWKRIRHPSEMVELNQELEVVILSVDKEKGRVALGLKQKEHNPWEDIEK
KYPPGKRITGKIVKLLPYGAFIEIEEGIEGLIHVSEMSWVKNVVDPSEVV
NKGDEVEAIVLSIQKDEGKISLGLKQTEHNPWDNIEEKYPIGLHVRAEIK
NLTNYGAFVELEPGIEGLIHISDMSWIKKVSHPSELFKKGSIVEAVILSV
DKESKKITLGVKQLSSNPWNEIEEMFPTGSVISGVVTKITAFGAFVELQN
GIEGLIHVSELSEKPFSKIEDIISIGDSVSAKVIKLDPDHKKVSLSVKEY
LADKQHDQTDTDIDDLDLEDLVSSDKKKKGK
>CAB047 rpsB, putative 30s ribosomal protein s2
MEEQPLCNLSVKDLMEAGAHFGHQTRRWNPKMKLYIFEEKNGLYIINLAK
TLYQLRKALPQVCKVIKENKPILFVGTKKQAKCVIKEAAIEAGEYFVAER
WLGGMLTNMTTIRNSIKTLDKIEKDLTQNSSYLTKKEIALLAKRHQKLLK
NLEGIRYLKKAPGLVIVVDPSYEKIAVAEAKKLGIPVLALVDTNCDPTPI
DYVIPCNDDSLKSIRLIISTIKDSIIDTKKKLGVEIVSPIKTLDIQDSED
MDVYATDEDNRQEDLLAKKYDSNEAN
>CAB099 rpsC, 30S ribosomal protein s3
MGQKGCPIGFRTGVTKKWRSLWYGNKQEFGKFLIEDVKIREFLRKKPSCQ
GAAGFVVRRMSGKIEVTIQTARPGLVIGKKGAEVDLLKEELRKLTGKEVW
VEIAEIKRPELNAKLVADNIARQIERRVSFRRAMKKAMQSVMDAGAVGVK
IQVSGRLAGAEIARSEWYKNGRVPLHTLRADIDYAAASAATTYGIIGVKV
WINLGEKASTASSNVGTAAPVVQ
>CAB108 rpsE, putative 30S ribosomal protein s5
MTLSKNSHKEDQLEEKVLVVNRCSKVVKGGRKFSFSALILVGDGKGRLGY
GFAKANELTDAIRKGGEAARKNLITIESLEGDSIPHEVLVDQDGAQLLLK
PAKPGTGIVAGSRIRLILEMAGVKNIVAKSLGSNNPMNQVKAAFKALLSL
SSRKDVLTRRKVTHD
>CAB787 rpsF, putative 30S ribosomal protein S6
MKEKTTQLYEGAYVFSVTLSEEARRKALEKVTSGITNYGGEILKIHDQGR
KKLAYTIRGAREGYYYLIYFTVVPGVIAELWKEYHLNEDLLRFLTLKTDA
VKEVLEFASLPE
>CAB187 rpsG, 30s ribosomal protein s7
MSRRHAAEKKIIPADPIYGSVTLERFINKVMMHGKKSIARKIVYNALERF
AKKVGAENVLEAFEEALENAKPLLEVRSRRVGGATYQVPVEVAAGRRDCL
AMQWIIKFARAKPGKSMEVGLATELVDCFNKQGATIKKREDTHRMAEANK
AFAHYKW
>CAB105 rpsH, putative 30S ribosomal protein s8
MGMTSDTIADLLTRIRNALKAEHLYVDLEHSKMREAIVKILKQHGFLAHY
LIKEEHRKRTMRIFLQYTNDRKPVIRQLKRVSKPSRRVYVPAAKIPYVFG
NMGISVLSTSQGVLDGSTARAKNIGGELLCLVW
>CAB519 rpsI, 30s ribosomal protein s9
MVKNTIEESVATGRRKQAVSSVRLRPGTGKIDVNGKAFDEYFPLEIQRVT
ILSPLKVLGYSNDFDLVIRINGGGIQGQVIATRLGLARALLKKNVDSKQE
LKSHGFLTRDPRKKERKKYGHKKARKSFQFSKR
>CAB189 rpsJ, 30S ribosomal protein s10
MLRSKEYMKQQKQKIRIRLKGFDQGQLDRSTADIVETAKRTGARVAGPIP
LPTKREVYTVLRSPHVDKKSREQFEIRTHKRLIDILDPTGKTIDALKMLA
LPAGVDIKIKAA
>CAB112 rpsK, putative 30s ribosomal protein s11
MVKHQAQKKGVKRKQLKNIPSGIVHVKATFNNTIVSITDPAGNTISWASA
GKVGYSGSRKSSAFAATVAAQDAAKIAMNSGLKEVEVCLKGTGAGRESAV
RALIAAGLVVSVIRDETPVPHNGCRPRKRRRV
>CAB111 rpsM, putative 30s ribosomal protein s13
MPRIIGIDIPAKKKLKISLTYIYGIGPALSEEIIAKLQLNPEARAAELTE
EEIGRLNSLLQSDYVVEGDLRRRVQSDIKRLISIHAYRGQRHRLSLPVRG
QRTKTNSRTRKGKRKTVAGKKK
>CAB802 rpsN, 30S ribosomal protein S14
MAKKSAVARENKRRKLVEANYKKRSELRKIAKSLTASEEEKENARVALNK
MKRDTAPIRLHNRCLLTGRPRGYLRKFAISRICFRQMASMGEIPGVVKAS
W
>CAB729 rpsO, 30S ribosomal protein S15
MSLDKGTKEEITKKFQLHEKDTGSADVQIAILTEHITELKEHLKRSPKDQ
NSRLALLKLVGQRRKLLEYLNSTDTERYKNLISRLNLRK
>CAB627A rpsP, 30s ribosomal protein s16
MALKIRLRQQGRRNHVVYRLVLADVESPRDGRYIELLGWYDPHSTVNYQL
KSDRIFHWLNQGAELTEKAAILIKQGAPGVYCELMAKRMARKAAVCQKRR
AYRQRRSLKRAEAKQSVVN
>CAB101 rpsQ, putative 30S ribosomal protein s17
MASEVRGLRKTKIGVVVSSKMDKTVVVRVERIYSHPQYAKVVRDSRKFYA
HDGLGVSEGDKVKIQETRPLSKLKRWRVVERVS
>CAB786 rpsR, 30S ribosomal protein S18
MNKPVHNKPVHNNEHRRKRFNKKCPFVSAGWKTIDYKDTETLKKFITEKG
KILPRRITGVSSRFQGILTLAIKRARHIGFLPFVGED
>CAB097 rpsS, putative 30S ribosomal protein s19
MSRSLRKGPFVDHSLIKKVRAMNLLEKKTPIKTWSRRSMITPEMIGHTFE
VHNGKKFLTVFVSETMVGHKLGEFSPTRIFKSHPVKKG
>CAB973 rpsT, 30s ribosomal protein S20
MAPKKTTKKGGPKKRPSAEKRIITSQKRCLINQSFKSKAKTMMKKFEAAL
KAGDQTSIASGLQLVYSVVDKAVKRGILKHNKAARIKSRATLRANAKI
>CAB317 rpsU, 30s ribosomal protein s21
MPSVKVRVGEPVDRALRILKKKVDKEGILKAAKAHRFYDKPSVKKRAKSK
AAAKYRSR
>CAB865 serS, seryl-tRNA synthetase
MLDIKLIRKAPEECETRLRKKDPLISLQPILDLDKEIRHLKTETEALQSQ
RKLLSNQIHKAKAQGEDVSSMMDNVERISQDLAKLEPLLEQKESTLQDML
VRLPNYPDEDVPVCPDKTGNQVIKQVGALPTFSFTPKHHVELNQKLQILD
FKLPAKTSGSGWPAYKNQGVCLEWALLTYLLNKQREHGFQLWLPPLLVKH
EILFGSGQIPKFDGQYYRVEDGEQSLYLIPTAEVVLNGFHSQEIFSEKDL
PIYYAAFTPCFRREAGAAGAHERGLVRVHQFHKVEMFAFTTPDQADQAYE
KMLAVVEDILTELQLPYRLSLLSTGDMSFTASKTIDAEVWLPGQQSYYEV
SSISQCTDFQSRRSETRYKDNRGKMHFVHTLNGSGLATPRLFVAILENNQ
QEDGSVIIPEVLRPYLENQEVLLP
>CAB926 thrS, threonyl-tRNA synthetase
MIRVICNNETYELPQGTTAADFASKIKNSHYFAGVVINDQIKDLSTTLNE
GDTLRFVTFTDPEGREIFLHTSAHILAQAILRLWPDAIPTIGPVIDQGFY
YDFANLSISEDDFLMIENMMGQIAEEKFAVQKKTFNSKHEALEEFARNPF
KVELIKELPEGESITAYSQGEFMDLCRGPHLPSTGPVKAFKLLRTSAAYW
RGDPQRESLVRIYGVAFPTTKELKEHLHQLKEAKKRDHRVLGMKLDLFSQ
QECSAGMPFFHPRGMIIWDALIGYWKRLHQLAGYKEIQTPQLMSRSLWEV
SGHWSNYRENMYTLKIEDEDYAIKPMNCPGCMLYYKTRLHSYKQFPLRIA
EIGHVHRYEVSGALSGLMRVRAFHQDDAHVFLTPEQVEEETLNILHLVSE
LYSTFGLEYHLELSTRPEKATIGSDELWELATAALERALVNSHTPFIINP
GDGAFYGPKIDIHVKDAIQRTWQCGTIQLDMFLPERFELEYTNAQGEKST
PVMLHRALFGSIERFLGILIEHFKGRFPLWLSPEHIRVITVADRHQPRAQ
KLATAWQKLGFVVTVDDSNESVSKKIRNAQNMQVNYMVTLGDREIEQNTL
AIRTRDNRVLNDMTEDKFLNTLLEEKNSLSLTPLL
>CAB627 trmD, putative tRNA(guanine-N(1)-)-methyltransferase
MKIDILSLFPEYFDSPLRSSILGRAIKRGLLDIQSRDIREFGLGKWKQVD
DAPFNHDGMLLMAEPVVKAIRHVKRSDSKVVYLSPQGQLLTAKKSRELAQ
CSHLIFLCGHYEGIDERALESEVDEEISIGDYVLTNGGIAALVVIDALSR
FIPGVLGNQESADKDSMENGLLEGPQYTRPRVFEGREVPEVLLHGDHQAI
AKWRKQISLDRTRERRPDLYIRYLYDRENEEVTQQETDLKQSMLEGESAV
ILEVEDLHRSRKFYSKMFRLNQPVNNRLHIPGKTQMTIHLQEVGLKSKNI
VLLSLRLGCKDDFFSFLGRWKMLGGTLEQADDRGEVRLVRDFDGHVWAIS
CKQAE
>CAB345 trmU, tRNA-methyltransferase
MNKTVVVAMSGGVDSSVVAYLLKKYTSYRVLGIFMKNWEEEDSNGLCSTA
KDYEDVERVAEQLDIPYYTVSFAREYRERVFSRFLKEYSQGYTPNPDVLC
NREIKFDLLQKKVVELGGDFLATGHYCRLDVKSQRVGLLRGKDPHKDQSY
FLCGTHPESLKNVLFPLGDMTKREVRSIAAQAGLATAQKRDSTGICFIGK
RPFKSFLEQFVPNVEGEIIDYDSQKIVGNHEGAHYYTIGQRRGLDIGGSE
KPCYVVGKDMEKNIVYIVRGEDHPLLYQQELTAKELNWFVSPESITRCSA
KVRYRSPDEECEILHTGTQDTVRVRFTSPVKAITPGQTIAFYDGERCLGG
GIIEVAMTPHSV
>CAB930 trpS, putative tryptophanyl-tRNA synthetase
MNKKTRVLTGDRPTGKLHLGHWVGSIKNRLDLQNNPAYDCFFIVADLHTL
TTRIRKEQVLNVDNHIYEVLADWLSVGIDPNKSTIYLQSAIPEIYELHLL
FSMLISINRIMGIPSLKEMAKNASIDEGGLSFGLVGYPVLQSADILLAKA
QLVPVGKDNEAHIELTRDIARNFNRLYGEIFPEPETLQGELTSLVGIDGQ
GKMSKSANNAIYLSDDDATIKDKIRKMYTDPNRIHATTPGRVEGNPLFIY
HDIFNPNKEEVEEFKTRYRQGCIKDVEIKARLAEELILFLQPLKEKRAEL
LTKPQALQDALQLGTEKMRAVAKETMEEVHDTLGLSHKWRSRLLP
>CAB159 truA, putative tRNA pseudouridine synthase a
MTQVVILLAYQGTAYAGWQRQPNDLSIQEVIENSLAQVVGKRIPVTSSGR
TDAEVHAFGQVAHFSQPDHPQFSQASSIKKMLNALLPKDIVIRDVVLGDD
KFHSRFSAIAKEYRYVLTRSPKPLPWERYFAYYPRHHLKTDLMQEGAQYL
LGTHDFASFANHGRDYTSTIRTLFNLDIVDHGETVTIICRGNGFLYKMVR
NIVGSLLDISRGKYPPEYIQEILMQKNRRQGPPAAPSHALSLYHVCYPKP
YHWFCTPECNINSLKEEK
>CAB449 truB, tRNA pseudouridine synthase B
MELATELKEGILLIDKPQGRTSFSLIRTLTKLIGVKKIGHAGTLDPFATG
VMVMLIGRRFTRLSDVLLFEDKEYAAVAHLGTTTDSYDCDGKIVGRSKKI
PTYEEILEASQYFQGEIQQIPPMFSAKKVNGKKLYEYARKGLSIERRQST
VQVSLQITKYEYPLLHFSIQCSKGTYIRSIAHELGNMLGCGAYLEELRRL
RSGSFSIDQCIDGCLLDCPDFDISPYLRDFNGNML
>CAB668 tuF, putative elongation factor Tu
MSKETFQRTKPHINIGTIGHVDHGKTTLTAAITRALSAEGLANFCDYSSI
DNTPEEKARGITINASHVEYETPNRHYAHVDCPGHADYVKNMITGAAQMD
GAILVVSATDGAMPQTKEHILLARQVGVPYIVVFLNKIDMISQEDAELVD
LVEMELSELLEEKGYKGCPIIRGSALKALEGDASYVEKIRELMQAVDDNI
PTPEREVDKPFLMPIEDVFSISGRGTVVTGRIERGVVKVGDKVQIVGLRD
TRETIVTGVEMFRKELPEGQAGENVGLLLRGIGKNDVERGMVICQPNSVK
SHTQFKGTVYILQKEEGGRHKPFFTGYRPQFFFRTTDVTGVVTLPEGVEM
VMPGDNVEFDVQLISPVALEEGMRFAIREGGRTIGAGTISKIIA
>CAB417 tyrS, tyrosyl-tRNA synthetase
MRDFIQHLQDRGILENFSSGLDNVSTPVSAYLGFDPTAPSLHIGHWIGIC
FLRRMAHFGLTPVALVGSATGMIGDPSGKSIERTLLEESQVAYNSQKLSE
CLAYYLPGVQIVNNIDWLKETTVIDFLRDVGKHFRLGVMLGKDTVKQRVQ
SEEGISYTEFSYMLLQSYDFAYLFENYGVCLQCGGSDQWGNITSGIDYIR
RHGLGQAYGLTYPLLTNSQGKKIGKTESGTIWLDPKLTSPYELYQYFLRL
PDQEVPKVARTLTLLSNEEIFDLDQKFLLDPVAVKKFVAETLVTSIHGED
GLREAQVVTQSIHPGKVSSVSEKDFQDLVAMGQAVSLEGTQALGKRWIDL
FVALGVCSSKGEARRLIEQKGLYVNSEPIENEHSVFEETQVCFDQYVLLA
QGKKKKLVLRLI
>CAB648 valS, valyl-tRNA synthetase
MEEDAFPKAYDPKGLEEKLYAFWEESTMFTAQAASDKPPYAIIMPPPNVT
GILHMGHALVNTLQDVLIRYKRMSGFEVCWVPGTDHAGIATQTVVERHLY
SSLGKRRVDFSREEFLEHVWQWKEKSEGVILSQLRQLGCSCDWSRLRFTM
EPLANRAVKKAFKILFDKGHIYRGNYLVNWDPVLQTALADDEVEYEEKDG
WLYYIRYRVVGSSEHIVVATTRPETLLGDTAIAISPDDERYSHLLGAKVH
LPFVDREIPIIADMSVDPLFGTGAVKITPAHDKDDYRTGMHHNLPMINIL
TPTGEINENGGIFAGLSKEKARESIITALETLGLFVKKEPYKLRVGVSYR
SGAVIEPYLSKQWFVSVDSFRDSLREFVASDAIKIFPPEFTKNYLTWVNN
LRDWCISRQLWWGHRIPVWYHKSDAHRMLCYDGEGIPEEVAKDPESWEQD
PDVLDTWFSSGLWPLTCLGWPDSECGDLEKFYPTAVLVTGHDILFFWVTR
MVLLCSAMVGKKPFSDVFLHGLIFGKSYKRYNDLGEWTYITGEEKYAYDM
GKALPKGVIAKWEKLSKSKGNVIDPLEMIAKYGADAVRMALCSCANRGEQ
IDLDYRLFEEYKNFANKIWNGARFIFSHISNLTSQDLARGIDTTLLGLED
YYILDGFNRLLKELHSAYQNYAFDKITTMAYEFFRNNFCSTYIEIIKPTL
YGKQRSKEDQLTKQKLLAVLLVNILGVLHPIAPFVTETLFLKLKEVIGEI
KEECSDAITAHALAMLRADSYVVAPYPQSIDIVIPEHLHESFALAERLVY
TVRNIRGEMQLDSRASLEVFVICPEGVSIETYVPMVCALGGISSIENLTE
EPKDRIYSLGVVEGIRLGVFVPVEHIAKEKTRLEKEKTRLENAIESASRL
LSSESFRAKANPDLVCAKEEALKNNRIELQSILDKLASFS